Lanean...
A randomized open-label trial on the use of budesonide/formoterol (Symbicort(®)) as an alternative reliever medication for mild to moderate asthmatic attacks
BACKGROUND: Conventionally, a nebulized short-acting β-2 agonist like salbutamol is often used as the reliever in acute exacerbations of asthma. However, recent worldwide respiratory outbreaks discourage routine use of nebulization. Previous studies have shown that combined budesonide/formoterol (Sy...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3352303/ https://ncbi.nlm.nih.gov/pubmed/22503137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1865-1380-5-16 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|